58
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Response to bronchodilators in very preterm infants with evolving bronchopulmonary dysplasia

, &
Pages 113-117 | Published online: 02 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vikramaditya Dumpa, Indirapriya Avulakunta & Vineet Bhandari. (2023) Respiratory management in the premature neonate. Expert Review of Respiratory Medicine 17:2, pages 155-170.
Read now
Marissa Hennelly, Rachel G Greenberg & Samia Aleem. (2021) An Update on the Prevention and Management of Bronchopulmonary Dysplasia. Pediatric Health, Medicine and Therapeutics 12, pages 405-419.
Read now

Articles from other publishers (4)

Rishika P. Sakaria & Ramasubbareddy Dhanireddy. (2022) Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?. Frontiers in Pediatrics 10.
Crossref
T. Lewis, W. Truog, L. Nelin, N. Napolitano & R. L. McKinney. (2021) Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia. Frontiers in Pharmacology 12.
Crossref
Alison W. Ha, Tara Sudhadevi, David L. Ebenezer, Panfeng Fu, Evgeny V. Berdyshev, Steven J. Ackerman, Viswanathan Natarajan & Anantha Harijith. (2020) Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology 319:3, pages L497-L512.
Crossref
Badr Hasan Sobaih. (2019) Influence of the level of maternal education on the long-term neurodevelopmental outcome of Saudi infants with birth weight of 1000-1500 grams at the age of 21-24 months. OA Journal of Pregnancy and Child Care 1:1.
Crossref